ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment

Bibliographic Details
Published in:Annals of Oncology
Main Authors: Kowalski, D.M., Reinmuth, N., Orlov, S.V., Fischer, J.R., Sugawara, S., Mandziuk, S., Medine, D.M., Novello, S., Takeda, Y., Soo, R.A., Park, K., McCleod, M., Geater, S.L., Powell, M., May, R., Stockman, P., Planchard, D.
Format: Article in Journal/Newspaper
Language:English
Published: Elsevier BV 2018
Subjects:
Oncology
Hematology
Arctic
Online Access:http://dx.doi.org/10.1093/annonc/mdy292.001
https://api.elsevier.com/content/article/PII:S0923753419497913?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753419497913?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy292.001/26140262/mdy292.001.pdf
id crelsevierbv:10.1093/annonc/mdy292.001
record_format openpolar
spelling crelsevierbv:10.1093/annonc/mdy292.001 2023-09-05T13:16:19+02:00 ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment Kowalski, D.M. Reinmuth, N. Orlov, S.V. Fischer, J.R. Sugawara, S. Mandziuk, S. Medine, D.M. Novello, S. Takeda, Y. Soo, R.A. Park, K. McCleod, M. Geater, S.L. Powell, M. May, R. Stockman, P. Planchard, D. 2018 http://dx.doi.org/10.1093/annonc/mdy292.001 https://api.elsevier.com/content/article/PII:S0923753419497913?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0923753419497913?httpAccept=text/plain http://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy292.001/26140262/mdy292.001.pdf en eng Elsevier BV https://www.elsevier.com/tdm/userlicense/1.0/ http://www.elsevier.com/open-access/userlicense/1.0/ Annals of Oncology volume 29, page viii493-viii494 ISSN 0923-7534 Oncology Hematology journal-article 2018 crelsevierbv https://doi.org/10.1093/annonc/mdy292.001 2023-08-23T17:17:39Z Article in Journal/Newspaper Arctic ScienceDirect (Elsevier - via Crossref) Arctic Annals of Oncology 29 viii493 viii494
institution Open Polar
collection ScienceDirect (Elsevier - via Crossref)
op_collection_id crelsevierbv
language English
topic Oncology
Hematology
spellingShingle Oncology
Hematology
Kowalski, D.M.
Reinmuth, N.
Orlov, S.V.
Fischer, J.R.
Sugawara, S.
Mandziuk, S.
Medine, D.M.
Novello, S.
Takeda, Y.
Soo, R.A.
Park, K.
McCleod, M.
Geater, S.L.
Powell, M.
May, R.
Stockman, P.
Planchard, D.
ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment
topic_facet Oncology
Hematology
format Article in Journal/Newspaper
author Kowalski, D.M.
Reinmuth, N.
Orlov, S.V.
Fischer, J.R.
Sugawara, S.
Mandziuk, S.
Medine, D.M.
Novello, S.
Takeda, Y.
Soo, R.A.
Park, K.
McCleod, M.
Geater, S.L.
Powell, M.
May, R.
Stockman, P.
Planchard, D.
author_facet Kowalski, D.M.
Reinmuth, N.
Orlov, S.V.
Fischer, J.R.
Sugawara, S.
Mandziuk, S.
Medine, D.M.
Novello, S.
Takeda, Y.
Soo, R.A.
Park, K.
McCleod, M.
Geater, S.L.
Powell, M.
May, R.
Stockman, P.
Planchard, D.
author_sort Kowalski, D.M.
title ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment
title_short ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment
title_full ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment
title_fullStr ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment
title_full_unstemmed ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment
title_sort arctic: durvalumab + tremelimumab and durvalumab monotherapy vs soc in ≥ 3l advanced nsclc treatment
publisher Elsevier BV
publishDate 2018
url http://dx.doi.org/10.1093/annonc/mdy292.001
https://api.elsevier.com/content/article/PII:S0923753419497913?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753419497913?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy292.001/26140262/mdy292.001.pdf
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_source Annals of Oncology
volume 29, page viii493-viii494
ISSN 0923-7534
op_rights https://www.elsevier.com/tdm/userlicense/1.0/
http://www.elsevier.com/open-access/userlicense/1.0/
op_doi https://doi.org/10.1093/annonc/mdy292.001
container_title Annals of Oncology
container_volume 29
container_start_page viii493
op_container_end_page viii494
_version_ 1776197961224552448

Similar Items